title: Reply to Decker et al.
authors.affiliation: Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health Department of Pediatrics.
authors.forename: Ruth
authors.initials: R
authors.lastname: Koepke
authors.affiliation: Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison.
authors.forename: Jens C
authors.initials: JC
authors.lastname: Eickhoff
authors.affiliation: Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health Department of Pediatrics.
authors.forename: Roman A
authors.initials: RA
authors.lastname: Ayele
authors.affiliation: Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health Department of Pediatrics.
authors.forename: Ashley B
authors.initials: AB
authors.lastname: Petit
authors.affiliation: Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health.
authors.forename: Stephanie L
authors.initials: SL
authors.lastname: Schauer
authors.affiliation: Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Hopfensperger
authors.affiliation: Department of Pediatrics.
authors.forename: James H
authors.initials: JH
authors.lastname: Conway
authors.affiliation: Bureau of Communicable Diseases and Emergency Response, Wisconsin Division of Public Health.
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Davis
mesh_terms: D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000627:therapeutic use*; D006801:Humans; D014917:Whooping Cough / Q000517:prevention & control*
chemical_list: D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines